Metropolitan Life Insurance Company (MetLife)’s KRONOS Worldwide KRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,240
| Closed | -$14.6K | – | 1138 |
|
|
2024
Q1 | $14.6K | Hold |
1,240
| – | – | ﹤0.01% | 2002 |
|
|
2023
Q4 | $12.3K | Hold |
1,240
| – | – | ﹤0.01% | 2110 |
|
|
2023
Q3 | $9.61K | Hold |
1,240
| – | – | ﹤0.01% | 2228 |
|
|
2023
Q2 | $10.8K | Buy |
1,240
+741
| +148% | +$6.53K | ﹤0.01% | 2256 |
|
|
2023
Q1 | $4.6K | Sell |
499
-992
| -67% | -$10.4K | ﹤0.01% | 2275 |
|
|
2022
Q4 | $14K | Hold |
1,491
| – | – | ﹤0.01% | 2165 |
|
|
2022
Q3 | $13.9K | Hold |
1,491
| – | – | ﹤0.01% | 2186 |
|
|
2022
Q2 | $27.4K | Hold |
1,491
| – | – | ﹤0.01% | 1877 |
|
|
2022
Q1 | $23.1K | Sell |
1,491
-4,357
| -75% | -$64.8K | ﹤0.01% | 2019 |
|
|
2021
Q4 | $87.8K | Sell |
5,848
-198
| -3% | -$2.76K | ﹤0.01% | 2545 |
|
|
2021
Q3 | $75K | Buy |
+6,046
| New | +$80K | ﹤0.01% | 2665 |
|
|
2021
Q2 | – | Sell |
-7,137
| Closed | -$109K | – | 2796 |
|
|
2021
Q1 | $109K | Sell |
7,137
-230
| -3% | -$3.45K | ﹤0.01% | 2391 |
|
|
2020
Q4 | $110K | Hold |
7,367
| – | – | ﹤0.01% | 2310 |
|
|
2020
Q3 | $94.7K | Hold |
7,367
| – | – | ﹤0.01% | 2249 |
|
|
2020
Q2 | $76.7K | Hold |
7,367
| – | – | ﹤0.01% | 2401 |
|
|
2020
Q1 | $62.2K | Buy |
7,367
+445
| +6% | +$4.67K | ﹤0.01% | 2309 |
|
|
2019
Q4 | $92.8K | Sell |
6,922
-1,050
| -13% | -$13.8K | ﹤0.01% | 2375 |
|
|
2019
Q3 | $98.6K | Hold |
7,972
| – | – | ﹤0.01% | 2311 |
|
|
2019
Q2 | $122K | Hold |
7,972
| – | – | ﹤0.01% | 2204 |
|
|
2019
Q1 | $112K | Hold |
7,972
| – | – | ﹤0.01% | 2260 |
|
|
2018
Q4 | $91.8K | Hold |
7,972
| – | – | ﹤0.01% | 2325 |
|
|
2018
Q3 | $130K | Hold |
7,972
| – | – | ﹤0.01% | 2295 |
|
|
2018
Q2 | $180K | Hold |
7,972
| – | – | ﹤0.01% | 2012 |
|
|
2018
Q1 | $180K | Hold |
7,972
| – | – | ﹤0.01% | 1956 |
|
|
2017
Q4 | $205K | Sell |
7,972
-8,308
| -51% | -$218K | ﹤0.01% | 1894 |
|
|
2017
Q3 | $372K | Hold |
16,280
| – | – | ﹤0.01% | 1878 |
|
|
2017
Q2 | $297K | Hold |
16,280
| – | – | ﹤0.01% | 2079 |
|
|
2017
Q1 | $267K | Hold |
16,280
| – | – | ﹤0.01% | 2078 |
|
|
2016
Q4 | $194K | Buy |
16,280
+1,284
| +9% | +$13K | ﹤0.01% | 2366 |
|
|
2016
Q3 | $124K | Buy |
+14,996
| New | +$106K | ﹤0.01% | 2525 |
|
|
2015
Q3 | – | Sell |
-13,926
| Closed | -$153K | – | 2690 |
|
|
2015
Q2 | $153K | Sell |
13,926
-3,290
| -19% | -$41.2K | ﹤0.01% | 2536 |
|
|
2015
Q1 | $218K | Buy |
17,216
+4
| +0% | +$49 | ﹤0.01% | 2023 |
|
|
2014
Q4 | $224K | Hold |
17,212
| – | – | ﹤0.01% | 2334 |
|
|
2014
Q3 | $237K | Hold |
17,212
| – | – | ﹤0.01% | 2256 |
|
|
2014
Q2 | $270K | Buy |
17,212
+16,611
| +2,764% | +$257K | ﹤0.01% | 2294 |
|
|
2014
Q1 | $10K | Hold |
601
| – | – | ﹤0.01% | 2717 |
|
|
2013
Q4 | $11K | Hold |
601
| – | – | ﹤0.01% | 2732 |
|
|
2013
Q3 | $9K | Buy |
601
+21
| +4% | +$331 | ﹤0.01% | 2750 |
|
|
2013
Q2 | $9K | Buy |
+580
| New | +$9.32K | ﹤0.01% | 2748 |
|
Other funds holding KRO
AAM
VLKIM
Metropolitan Life Insurance Company (MetLife)'s KRO Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of KRONOS Worldwide (KRO) in Q2 2024, closing a stake of 1,240 shares — an estimated $14.6K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in KRO in Q2 2013 and held it in 39 quarters. The position peaked at $372K in Q3 2017. 137 funds tracked by Wall St. Rank hold KRO as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining KRONOS Worldwide position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,240 KRONOS Worldwide shares in Q2 2024, an estimated $14.6K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in KRONOS Worldwide in Q2 2013 and held it in 39 quarters.
- Metropolitan Life Insurance Company (MetLife)'s KRONOS Worldwide position peaked at $372K in Q3 2017.
- 137 funds tracked by Wall St. Rank held KRONOS Worldwide as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.